Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
A Phase III Randomized, Double-Blind Placebo-Controlled Study of BKM120 with Fulvestrant, in Post-Menopausal Women with Hormone Receptor-Positive HER2-Negative Locally Advanced or Metastatic Breast Cancer Which Progressed on or after Aromatase Inhibitor Treatment.
Not Open (Closed)
Defintions of terms and FAQ about clinical trials.
Darcy Spicer, M.D.
Other Trial Staff:
Kristy Watkins, R.N., Yanli Wang, D.M.
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.